FDA recall Z-0849-2020
Vitreq Bv · Class II · device
Product
VitreQ 23G PFC Injection Needle- Ref: MD23.D01 GTIN: 8719214221362
Reason for recall
Microscopic tears of the sterile pouch may compromise sterility
Distribution
Nationwide
Key facts
- Status
- Terminated
- Initiation date
- 2019-12-17
- Report date
- 2020-02-05
- Termination date
- 2020-12-09
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Vierpolders, N/A, Netherlands
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0849-2020